Delivery Order SPE2DB20D1004-SPE2DB24FG6W4

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,554,756,127 units of the drug PRADAXA 150 MG CAPSULE. The contract has a firm fixed price ceiling value of $1,334.33 and an ultimate completion date of September 14, 2021. The contract is a delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,699.03 and a completion date of May 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,777.68 firm fixed-price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a cardiovascular medication. The contract has an ultimate completion date of September 2, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,018.15 firm fixed price delivery order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a prescription medication. The contract has an ultimate completion date of April 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pradaxa 150 mg capsules, with a ceiling value of $9,809.06 and a performance period through December 22, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, identified as SPE2DB20D1004|SPE2DB24FF8Z7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,601.97 firm fixed-price delivery order is for the supply of 4564404280 - PRADAXA 150 MG CAPSULE UU 60S. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award Management...
The U.S. Defense Logistics Agency (DLA) awarded a $37,269.81 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,203.80 firm fixed-price delivery order is for the supply of Pradaxa 75 mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of 150mg Pradaxa capsules to the Defense Logistics Agency (DLA). The $1,914.27 firm fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award has an ultimate completion date of May 15, 2024 and was not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,338.60 and is for the delivery of PRADAXA 150 MG CAPSULE UD 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2025. There is no set-aside designation for this contract, indicating it was open competition....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG6W4
    Delivery Order

This federal contract award, valued at $10,538.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with an ultimate completion date of August 20, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:23 PM